2013 EACPT Geneva Congress Symposia: Clinical trial regulation, control and benefits

-->

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications

Symposium on clinical trial regulation, control and benefits

In July 2012, the European Commission adopted a proposal for a Regulation on Clinical Trials. This is now under discussion by the European Parliament and the Council. Input from affected stakeholders is deemed also critical to end up in an optimised legislative framework for clinical trials in Europe. During next year the discussion process should be reaching its end. This session will be a unique opportunity to share and discuss first hand opinions from two key stakeholders intervening in clinical trials, regulatory bodies and academia, and discuss together benefits and risks associated to the legislative proposal.

2013 EACPT Congress

Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org 

2013 EACPT Geneva Congress Symposia: Drug-Drug Interactions

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications

Symposium on Drug-Drug Interactions

Drug-drug interaction is one of the major problems in therapeutics associated with the use of drugs. Given the aging of the population, polymedication and the continuous development of new drugs, the occurrence of clinically significant drug-drug interactions will dramatically increase. Metabolic enzymes as well as drug transporters are frequently involved in DDI. In vitro-in vivo extrapolation (IVIVE) methodology is widely used in drug discovery and huge effort in both academia and industry has focused on developing reliable methods to predict DDI. During this session, you will have the opportunity to discuss with international experts in the field the state of the art in predicting the magnitude of DDI at the individual level, the clinical pertinence and the role of transporters in drug interactions.

EACPT Congress 2103
Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org 

EACPT Geneva Congress Symposia: Drug-induced liver injury

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications

Symposium on drug-induced liver injury

Drug-induced liver injury (DILI) is a rare but clinically important problem. Many different drugs can cause DILI, with the pattern of injury varying between drugs. A better understanding of the genetic and environmental factors that are associated with DILI will allow the development of strategies to identify susceptible individuals prior to prescription. Current detection methods do not provide insight into injury mechanisms and do not allow prediction of clinical outcomes of liver injury. This session will focus on the molecular mechanisms that cause DILI, novel biomarkers for the diagnosis of DILI and current approaches towards classifying DILI within clinical studies.

Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org 

2013 EACPT Geneva Congress Symposia: Assessing and supporting tomorrow’s prescribers

Abstract submission is now open for the next EACPT Congress, to be held in Geneva 28-31 August 2013. The congress includes symposia, keynote lectures and peer-reviewed oral and poster communications

Assessing and supporting tomorrow’s prescribers

Prescribing is core business for most healthcare organisations and the major tool used to influence the course of their patients' illnesses as well as to prevent future disease. Much of the workload is undertaken by relatively junior doctors and there is accumulating evidence that avoidable adverse drug reactions and prescribing errors are common. This symposium will address several issues that are relevant to this problem. First, it will examine the development of assessments that might predict poor prescribing performance and the need for further training. Second, it will highlight how prescribing education might be improved. Third, it will look at the potential for electronic prescribing solutions to improve quality. Finally, the impact of implementing standardised prescribing documentation will be discussed.

Over 900 participants are expected to attend including health professionals, scientists, policy makers, biotechnology and pharmaceutical professionals, and others with an interest in basic and clinical pharmacology, pharmacotherapy, drug discovery and development, regulatory affairs and related areas.

See here for more on key themes of the Congress.

EACPT Geneva 2013 Congress website  www.eacpt2013.org 

Updates on sessions at EACPT Congress, Geneva 2013

European Association for Clinical Pharmacology & Therapeutics: 11th International Congress: 

Geneva, August 28th - 31st, 2013

British Pharmacological Society Prescribing Symposium

Wednesday 28th August 2013

Session organiser: Professor Simon Maxwell

  

- First, it will examine the development of assessments that might predict poor prescribing performance and the need for further training. 

- Second, it will highlight how prescribing education might be improved. 


- Third, it will look at the potential for electronic prescribing solutions to improve quality. 


- Finally, the impact of implementing standardised prescribing documentation will be discussed.

 Registration will open 10^th November 2012. Abstract submissions on the above and other Congress themes will also open 10^th November 2012 and will close 15^th April 2013. To receive updates on the congress before registering, you can submit your email address to the congress organisers.

For further information on the August 2013 Congress

Congress Website: http://www.eacpt2013.com

Secretariat email